2015
DOI: 10.1016/bs.enz.2015.05.002
|View full text |Cite
|
Sign up to set email alerts
|

Potential Anticancer Properties and Mechanisms of Action of Withanolides

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
22
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
4
2
1

Relationship

0
7

Authors

Journals

citations
Cited by 25 publications
(22 citation statements)
references
References 123 publications
(149 reference statements)
0
22
0
Order By: Relevance
“…In the same study, incubation of WFA with strong reducing agents like N-acetyl cysteine or DTT resulted into loss of the pro-apoptotic activity of WFA [53]. On the other hand, loss of unsaturation in the A-ring have been reported to cause loss of anti-inflammatory and antiangiogenic effects of WFA [43,54].…”
Section: A B Cmentioning
confidence: 86%
See 3 more Smart Citations
“…In the same study, incubation of WFA with strong reducing agents like N-acetyl cysteine or DTT resulted into loss of the pro-apoptotic activity of WFA [53]. On the other hand, loss of unsaturation in the A-ring have been reported to cause loss of anti-inflammatory and antiangiogenic effects of WFA [43,54].…”
Section: A B Cmentioning
confidence: 86%
“…These biological activities include anti-inflammatory, anticancer, antiangiogenic, cardioprotective, immunomodulatory, hepatoprotective, anticonvulsant and anabolic effects [43,51]. However, in the past decade or so, WFA has attracted significant attention and testing mainly for its anticancer activity [44].…”
Section: A B Cmentioning
confidence: 99%
See 2 more Smart Citations
“…Together, the combination of these scores allows the NSCLC cases to be grouped into the seven stages; IA, IB, IIA, IIB, IIIA, IIIB, and V. For prognostic purposes, the NSCLC cases assigned to stages IA, IB, IIA, and IIB are generally considered to be in the early-stages of the disease. For these early-stages of NSCLC, the primary tumors are associated with no evidence of local or distant metastases [20,21]. On the other hand, NSCLC cases that display tumor descriptors which fall into the stages III-V display evidence of metastatic nodules in the regional lymph nodes and/or distant organs.…”
Section: The Nsclc Staging Systemmentioning
confidence: 99%